Kedar Joshi

582 total citations
14 papers, 311 citations indexed

About

Kedar Joshi is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Kedar Joshi has authored 14 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Kedar Joshi's work include HIV/AIDS drug development and treatment (5 papers), HIV/AIDS Research and Interventions (3 papers) and HIV Research and Treatment (3 papers). Kedar Joshi is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV/AIDS Research and Interventions (3 papers) and HIV Research and Treatment (3 papers). Kedar Joshi collaborates with scholars based in India, United States and Nepal. Kedar Joshi's co-authors include Deepak Langade, Sanjay Pujari, Rohini Handa, L S Bichile, Arvind Chopra, Manjit Saluja, Girish Tillu, Venil N. Sumantran, Bhushan Patwardhan and Sanjay Bhagani and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Lara D. Veeken and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Kedar Joshi

14 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kedar Joshi India 7 163 53 48 46 34 14 311
Susan Arentz Australia 10 60 0.4× 32 0.6× 34 0.7× 64 1.4× 31 0.9× 22 459
Shi-Bing Liang China 10 83 0.5× 15 0.3× 48 1.0× 66 1.4× 56 1.6× 28 274
Shenghui Zhao China 10 77 0.5× 52 1.0× 33 0.7× 168 3.7× 69 2.0× 14 362
Mina Darand Iran 14 70 0.4× 31 0.6× 18 0.4× 72 1.6× 60 1.8× 50 467
Chaturbhuja Nayak India 11 259 1.6× 41 0.8× 30 0.6× 21 0.5× 30 0.9× 67 392
Soobin Jang South Korea 10 104 0.6× 7 0.1× 89 1.9× 56 1.2× 34 1.0× 62 347
Jessie Hawkins United States 9 65 0.4× 11 0.2× 13 0.3× 43 0.9× 31 0.9× 18 299
Alessandra Miccono Italy 8 34 0.2× 62 1.2× 35 0.7× 60 1.3× 31 0.9× 10 391
Ryutaro Arita Japan 11 94 0.6× 12 0.2× 30 0.6× 57 1.2× 169 5.0× 57 392
Fatemeh Amini Iran 8 21 0.1× 48 0.9× 24 0.5× 42 0.9× 38 1.1× 16 271

Countries citing papers authored by Kedar Joshi

Since Specialization
Citations

This map shows the geographic impact of Kedar Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kedar Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kedar Joshi more than expected).

Fields of papers citing papers by Kedar Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kedar Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kedar Joshi. The network helps show where Kedar Joshi may publish in the future.

Co-authorship network of co-authors of Kedar Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Kedar Joshi. A scholar is included among the top collaborators of Kedar Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kedar Joshi. Kedar Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Joshi, Kedar, et al.. (2024). EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years. Value in Health. 27(6). S89–S90. 1 indexed citations
2.
Pujari, Sanjay, et al.. (2023). Effectiveness, Weight Changes, and Metabolic Outcomes on Switch to Generic Dolutegravir/Lamivudine Among People with HIV in Western India: An Observational Study. AIDS Research and Human Retroviruses. 40(4). 204–215. 1 indexed citations
3.
Pujari, Sanjay, et al.. (2021). Short Communication: Coronavirus Disease 19 Among People Living with HIV in Western India: An Observational Cohort Study. AIDS Research and Human Retroviruses. 37(8). 620–623. 6 indexed citations
4.
Pujari, Sanjay, et al.. (2021). Long‐coronavirus disease among people living with HIV in western India: An observational study. Immunity Inflammation and Disease. 9(3). 1037–1043. 25 indexed citations
5.
6.
Pujari, Sanjay, et al.. (2020). Effectiveness of dolutegravir-based antiretroviral treatment for HIV-2 infection: retrospective observational study from Western India. Journal of Antimicrobial Chemotherapy. 75(7). 1950–1954. 6 indexed citations
7.
Sharma, Bimala & Kedar Joshi. (2017). Treatment adherence of antiretroviral therapy among people living with HIV/AIDS. Journal of Chitwan Medical College. 6(3). 56–61. 1 indexed citations
8.
Joshi, Kedar, et al.. (2016). Use of Proton Pump Inhibitors-A drug utilization study. Indian Journal of Pharmacy and Pharmacology. 3(2). 88–88. 4 indexed citations
9.
Joshi, Kedar, et al.. (2016). Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract. Journal of Evidence-Based Complementary & Alternative Medicine. 22(1). 96–106. 84 indexed citations
10.
Joshi, Kedar, et al.. (2016). Proton pump inhibitors: are they safe on kidneys: a histopathological study. International Journal of Basic & Clinical Pharmacology. 1187–1192. 1 indexed citations
11.
Langade, Deepak, et al.. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition. 12(1). 43–43. 93 indexed citations
12.
Pujari, Sanjay, Colette Smith, Mike Youle, et al.. (2014). Higher risk of renal impairment associated with tenofovir use amongst people living with HIV in India: A comparative cohort analysis between Western India and United Kingdom. BMC Infectious Diseases. 14(1). 173–173. 16 indexed citations
13.
Pujari, Sanjay, et al.. (2013). Short-Term Effectiveness and Safety of Third-Line Antiretroviral Regimens Among Patients in Western India. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(2). e82–e84. 4 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susan Arentz Breakdown of academic impact, for papers by Shi-Bing Liang Breakdown of academic impact, for papers by Shenghui Zhao Breakdown of academic impact, for papers by Mina Darand Breakdown of academic impact, for papers by Chaturbhuja Nayak Breakdown of academic impact, for papers by Soobin Jang Breakdown of academic impact, for papers by Jessie Hawkins Breakdown of academic impact, for papers by Alessandra Miccono Breakdown of academic impact, for papers by Ryutaro Arita Breakdown of academic impact, for papers by Fatemeh Amini
Rankless by CCL
2026